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Abstract: A practical synthesis of a tripeptide containing a ketomethylene isostere, suitably protected for
introduction in Fmoc SPPS, has been carried out  for the first time in Fmoc chemistry by using a
modified Dakin-West reaction.
In recent years, the use of peptides bearing modified isostere amide bond has been more and more widespread in the study of
biological systems as enzymes and receptors.1 Among more than dozen different isosteres, the ketomethylene isostere Ψ(CO-CH2)
has been widely used to design hydrolytically stable peptides.2 Furthemore, and in addition to a higher conformational freedom, this
amide bond replacement maintains the H-bond acceptor capacity of the CO group and that property has been used to probe the
interaction between receptors and ligands.3
During our study of Major Histocompatibility Complex (MHC) class II-peptide interactions implicated in immune response,
we have used as model the 52-61 peptidic fragment derived from the Hen Egg Lysozyme, HEL(52-61) , and synthetized several
analogues showing that efficient binding to MHC Class II molecules requires a complex, nonrandom combination of residues with
appropriate orientation of the peptide backbone and some crucial side chains.4
Recent X-ray studies5 of a human MHC Class II-peptide complex have shown that hydrogen bonding networks between side-
chains of the MHC residues and the amide bonds of the peptide backbone appear to be essential for an optimal binding in addition to
one additional anchor residue. So, we planned to replace the Tyr-Gly amide bond of HEL(52-61) by different isosteres and especially
ketomethylene one to probe those interactions.
Several synthetic approaches of linear ketomethylene isostere have been described in the literature, e.g. addition of Grignard
reagents on aldehydes6 or activated acids7, alkylation of malonic derivatives8 or use of the Dakin-West reaction.9 Among all these
strategies, we were looking for an efficient and expeditious method compatible with 9-Fluorenylmethoxycarbonyl (Fmoc)-based Solid
Phase Peptide Synthesis (SPPS). In 1985, Mc Murray and Dyckes9b exposed the synthesis of ketomethylene peptidic analogues based
on a modification of the Dakin-West reaction by Steglish and Hoefle.10 Nα-Acyl amino acids, dipeptides or tripeptides possessing a
free carboxyl function at the C-terminus are heated at 40-50°C with triethylamine and 4-dimethylaminopyridine (DMAP) and the
appropriate anhydride. A subsequent decarboxylation step then yields carboxy 
terminal β-ketones. It must be stressed that the chirality of the penultimate α-carbon is lost.
Mc Murray and Dyckes stated this strategy would be impracticable with base labile protecting group. However, close study of
the literature11 showed that Fmoc protective group could be compatible with the conditions of Mc Murray and Dyckes reaction. Our
strategy to obtain the corresponding Tyr-Gly ketomethylene derivative of HEL(52-61) requires the synthesis of the protected
tripeptide Fmoc-Nα-Asp(tBu)-Tyr(tBu)-Ψ(CO-CH2)Gly-OH.
First of all, the synthesis of the dipeptide Fmoc-Nα-Asp(tBu)-Tyr(tBu)OH 412 has been carried out in solution by coupling of
Fmoc-Nα-Asp(tBu)OSu with O-tButyl protected tyrosine with 75% yield in DMF/DMSO mixture because of poor solubility of
tyrosine.
The Dakin-West reaction requires a suitably mono-protected anhydride so as to deprotect then the C-terminus carboxyle for
introduction in the HEL(52-61) sequence. Allyl ester would be the best protecting group allowing its selective deprotection by Pd(0)
complex.11 In order to obtain the suitably protected anhydride, succinic anhydride 1 was opened by allyl alcohol in toluene at reflux
with DMAP to give the mono-acid 213 with 90% yield. Finally, the synthesis of the anhydride 314 was carried out by coupling with
water soluble coupling agent 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC), and used immediately for the subsequent
Dakin-West reaction.
The Dakin-West reaction between the dipeptide 4 and the anhydride 3 was performed according to Mc Murray and Dyckes
conditions9b except CH2Cl2 was used as solvent. The ketomethylene 515 was obtained after flash chromatography with good yield.
a. i) Et3N, DMAP cat., CH2Cl2, reflux, 1h. ii) removal of solvents in vacuo. iii) NaHCO3 5%, r.t., 30mn, 74%.
b. Pd(Ph3)4, CH3(CH2)3CH(C2H5)COOK, AcOEt/CH2Cl2, r.t., 1h, 71%.
As expected, 1H NMR spectrum of the ketomethylene 515 shows a 50:50 diastereomeric mixture owing to the racemisation of
t h e α tyrosine carbon.9 b No detectable separation of the two diastereomers has been noted during purification by flash
chromatography or control of the purity by HPLC.
Finally, the target molecule 616 was obtained with 71% yield by treatment of 5 with Pd(0) complex in presence of potassium
2-ethylhexanoate17 as scavenger.
In conclusion, we have shown for the first time that Dakin-West reaction could be applied to Fmoc chemistry by synthetizing
the ketomethylene tripeptide Fmoc-Nα-Asp(tBu)-(R,S)Tyr(tBu)Ψ(CO-CH2)Gly-OH in good overall yield. The incorporation of this
compound in the HEL(52-61) sequence and the biological activity of the corresponding ketomethylene peptide will be described in
due course.
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